2013

As reported in the Wall Street Journal and Smart Brief: "Businesses are confused as to whether to act now or wait for the U.S.…

With the Physician Payment Sunshine Act period of reporting for 2013 drawing to a close end, it will be critical for all…

The Physician Payment Sunshine Act (Open Payments) Final Rule has not clarified all of the expectations under the law. The…

In May 2010, the Food and Drug Administration's (FDA) Office of Prescription Drug Promotion (OPDP) launched the Bad Ad program.…

Compliance managers at pharmaceutical companies and medical device manufacturers can stay ahead of enforcement trends by…

According to a release from the Centers for Medicare & Medicaid Services (CMS), in response to stakeholder requests, on…

Adverse drug events (ADEs) have been defined as an injury resulting from medical intervention related to a drug. ADEs can occur in…

A recent post at Health Affairs blog calls for reforming the physician certification process. It is authored by Dr. Alan Muney,…

The FDA has unveiled a "A Parents' Guide to Kids' Vaccines" on its website. The website outlines several key areas:…

According to Regulatory Focus, in response to "unparalleled challenges" posed by advances in science, globalization and product…